Decoupled Glucose and Lipid Metabolic Recovery after Viral Clearance in Direct-Acting Antiviral-Treated HCV Patients: A 3-Year Prospective Cohort Study

Background/Aim: The recovery pattern of hepatitis C virus (HCV)-associated metabolic alteration after sustained virological response (SVR) following direct-acting antivirals (DAAs) remains elusive. Methods: A prospective cohort study of chronic HCV-infected (CHC) patients (n = 415) receiving DAAs (n...

Full description

Bibliographic Details
Main Authors: Heng Lee, Rong-Nan Chien, Li-Heng Pao, Chia-Jung Kuo, Po-Han Huang, Ming-Ling Chang
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/11/2934
_version_ 1797510845227335680
author Heng Lee
Rong-Nan Chien
Li-Heng Pao
Chia-Jung Kuo
Po-Han Huang
Ming-Ling Chang
author_facet Heng Lee
Rong-Nan Chien
Li-Heng Pao
Chia-Jung Kuo
Po-Han Huang
Ming-Ling Chang
author_sort Heng Lee
collection DOAJ
description Background/Aim: The recovery pattern of hepatitis C virus (HCV)-associated metabolic alteration after sustained virological response (SVR) following direct-acting antivirals (DAAs) remains elusive. Methods: A prospective cohort study of chronic HCV-infected (CHC) patients (n = 415) receiving DAAs (n = 365) was conducted. Metabolic profiles were examined in SVR patients (n = 360) every 3–6 months after therapy and compared with those of sex- and age-matched controls (n = 470). Results: At baseline, of 415, 168 (40.5%) had insulin resistance (IR). The following were associated: levels of high-density lipoprotein cholesterol (HDL-C), triglycerides (TGs), HCV RNA, fibrosis-4 score, and interferon-λ3-rs12979860 genotype with total cholesterol (TC) levels; and TG levels and BMI with HOMA-IR. Over a 3-year follow-up, in SVR patients, BMI and TC levels and TG/HDL-C ratios increased from baseline, while HOMA-IR trended downward by 72 weeks after therapy and then increased. The increased HDL-C levels began to decrease after 72 weeks after therapy. TC and HOMA-IR were negatively associated with each other until 24 weeks after therapy. Earlier increases in BMI and decreases in HOMA-IR were noted in SVR patients with than in those without baseline IR. Compared with controls, in the subgroup without baseline IR, SVR patients had increased BMI and HOMA-IR levels. Metabolic profiles were similar between SVR patients and controls in the subgroup with baseline IR. Conclusions: In SVR patients treated with DAAs, the recovery of altered lipid and glucose metabolism was not coupled until 72-week post-therapy, when HOMA-IR reached its nadir. SVR patients with baseline IR recovered from HCV-associated metabolic alterations earlier than those without baseline IR.
first_indexed 2024-03-10T05:37:06Z
format Article
id doaj.art-23b88b3708994bc7bcaa0a9a98ee95bb
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T05:37:06Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-23b88b3708994bc7bcaa0a9a98ee95bb2023-11-22T22:48:54ZengMDPI AGCells2073-44092021-10-011011293410.3390/cells10112934Decoupled Glucose and Lipid Metabolic Recovery after Viral Clearance in Direct-Acting Antiviral-Treated HCV Patients: A 3-Year Prospective Cohort StudyHeng Lee0Rong-Nan Chien1Li-Heng Pao2Chia-Jung Kuo3Po-Han Huang4Ming-Ling Chang5Department of Medicine, College of Medicine, Chang Gung University, Taoyuan 333323, TaiwanDepartment of Medicine, College of Medicine, Chang Gung University, Taoyuan 333323, TaiwanGraduate Institute of Health Industry Technology, Chang Gung University of Science and Technology, Taoyuan 33303, TaiwanDepartment of Medicine, College of Medicine, Chang Gung University, Taoyuan 333323, TaiwanDepartment of Medicine, College of Medicine, Chang Gung University, Taoyuan 333323, TaiwanDepartment of Medicine, College of Medicine, Chang Gung University, Taoyuan 333323, TaiwanBackground/Aim: The recovery pattern of hepatitis C virus (HCV)-associated metabolic alteration after sustained virological response (SVR) following direct-acting antivirals (DAAs) remains elusive. Methods: A prospective cohort study of chronic HCV-infected (CHC) patients (n = 415) receiving DAAs (n = 365) was conducted. Metabolic profiles were examined in SVR patients (n = 360) every 3–6 months after therapy and compared with those of sex- and age-matched controls (n = 470). Results: At baseline, of 415, 168 (40.5%) had insulin resistance (IR). The following were associated: levels of high-density lipoprotein cholesterol (HDL-C), triglycerides (TGs), HCV RNA, fibrosis-4 score, and interferon-λ3-rs12979860 genotype with total cholesterol (TC) levels; and TG levels and BMI with HOMA-IR. Over a 3-year follow-up, in SVR patients, BMI and TC levels and TG/HDL-C ratios increased from baseline, while HOMA-IR trended downward by 72 weeks after therapy and then increased. The increased HDL-C levels began to decrease after 72 weeks after therapy. TC and HOMA-IR were negatively associated with each other until 24 weeks after therapy. Earlier increases in BMI and decreases in HOMA-IR were noted in SVR patients with than in those without baseline IR. Compared with controls, in the subgroup without baseline IR, SVR patients had increased BMI and HOMA-IR levels. Metabolic profiles were similar between SVR patients and controls in the subgroup with baseline IR. Conclusions: In SVR patients treated with DAAs, the recovery of altered lipid and glucose metabolism was not coupled until 72-week post-therapy, when HOMA-IR reached its nadir. SVR patients with baseline IR recovered from HCV-associated metabolic alterations earlier than those without baseline IR.https://www.mdpi.com/2073-4409/10/11/2934HCVmetabolic alterationlipidHOMA-IRDAA
spellingShingle Heng Lee
Rong-Nan Chien
Li-Heng Pao
Chia-Jung Kuo
Po-Han Huang
Ming-Ling Chang
Decoupled Glucose and Lipid Metabolic Recovery after Viral Clearance in Direct-Acting Antiviral-Treated HCV Patients: A 3-Year Prospective Cohort Study
Cells
HCV
metabolic alteration
lipid
HOMA-IR
DAA
title Decoupled Glucose and Lipid Metabolic Recovery after Viral Clearance in Direct-Acting Antiviral-Treated HCV Patients: A 3-Year Prospective Cohort Study
title_full Decoupled Glucose and Lipid Metabolic Recovery after Viral Clearance in Direct-Acting Antiviral-Treated HCV Patients: A 3-Year Prospective Cohort Study
title_fullStr Decoupled Glucose and Lipid Metabolic Recovery after Viral Clearance in Direct-Acting Antiviral-Treated HCV Patients: A 3-Year Prospective Cohort Study
title_full_unstemmed Decoupled Glucose and Lipid Metabolic Recovery after Viral Clearance in Direct-Acting Antiviral-Treated HCV Patients: A 3-Year Prospective Cohort Study
title_short Decoupled Glucose and Lipid Metabolic Recovery after Viral Clearance in Direct-Acting Antiviral-Treated HCV Patients: A 3-Year Prospective Cohort Study
title_sort decoupled glucose and lipid metabolic recovery after viral clearance in direct acting antiviral treated hcv patients a 3 year prospective cohort study
topic HCV
metabolic alteration
lipid
HOMA-IR
DAA
url https://www.mdpi.com/2073-4409/10/11/2934
work_keys_str_mv AT henglee decoupledglucoseandlipidmetabolicrecoveryafterviralclearanceindirectactingantiviraltreatedhcvpatientsa3yearprospectivecohortstudy
AT rongnanchien decoupledglucoseandlipidmetabolicrecoveryafterviralclearanceindirectactingantiviraltreatedhcvpatientsa3yearprospectivecohortstudy
AT lihengpao decoupledglucoseandlipidmetabolicrecoveryafterviralclearanceindirectactingantiviraltreatedhcvpatientsa3yearprospectivecohortstudy
AT chiajungkuo decoupledglucoseandlipidmetabolicrecoveryafterviralclearanceindirectactingantiviraltreatedhcvpatientsa3yearprospectivecohortstudy
AT pohanhuang decoupledglucoseandlipidmetabolicrecoveryafterviralclearanceindirectactingantiviraltreatedhcvpatientsa3yearprospectivecohortstudy
AT minglingchang decoupledglucoseandlipidmetabolicrecoveryafterviralclearanceindirectactingantiviraltreatedhcvpatientsa3yearprospectivecohortstudy